Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SynaptiCure

Explore full profile

Comprehensive ALS care platform integrating specialized neurology and local care coordination for optimized patient outcomes

Chicago, United StatesFounded 2019Health Tech & Medtech
Valuation $100–250M Last recorded · 2024
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for SynaptiCure and the history behind them.

About SynaptiCure

Synapticure.com is a telehealth startup that provides virtual care for individuals and caregivers dealing with neurodegenerative diseases such as ALS, Alzheimer’s, Huntington's, and Parkinson’s. The company operates in the healthcare market, specifically in the telehealth and neurology sectors.

The business model is centered around providing 24/7 access to neurologists, behavioral health providers, and care coordinators via telehealth. This means patients and caregivers can book appointments and receive care from the comfort of their own homes, without the need to travel to a physical location. This is particularly beneficial for those with mobility issues or who live in remote areas.

Synapticure also offers integrated behavioral health services, recognizing the emotional and psychological challenges that come with neurodegenerative diseases. The company prides itself on being informed by the latest science, helping patients understand their options and access new treatments or enroll in clinical trials.

The company generates revenue through the fees charged for the telehealth services provided. These fees are likely paid by the patients themselves, their insurance companies, or a combination of both.

The co-founders, Brian Wallach and Sandra Abrevaya, have personal experience with ALS, which adds a layer of empathy and understanding to the services provided. The company has received positive reviews for its knowledgeable and empathetic doctors, who are described as being on the cutting edge of neurodegenerative disease treatment.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Chicago, United States
Employees
106
Open positions
6
Dealroom signal
85.8/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Healthcare Services, Neurology, Mental Health, YC S20
Client focus
b2b, b2c

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Nov 2024 $25M $100M RA Capital Management · Rock Health Capital · CVS Health Ventures · GV ↗
SEEDEquity / VC Nov 2022 $0 — Rebel Fund —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

SynaptiCure website traffic

Latest recorded traffic for SynaptiCure is 19K monthly website visits, down 38.7% over the last three months. SynaptiCure's team grew 14% over the past year.

Latest monthly visits19K 3-month web change-38.7% 1-year team growth+14%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
MentaviTelehealth company offering mental health assessments and care, including through its affiliated platform, ADHD Online Grand Rapids Charter Township, United States Operational 46 $2.1M $8.3M
ADHD OnlineOffers psychologist-reviewed ADHD assessments and treatment planning, screening for related mental health conditions Grand Rapids Charter Township, United States Operational
BioMinds Healthcare Sp. z o.o.A new way for neurological rehabilitation - system for remote rehabilitation operating in augmented and virtual reality for sick and healthy persons Lublin, Poland Operational
OptoceuticsAdvancing non-invasive light technologies, based on gamma light therapy, to stimulate the brain and improve cognitive function Kongens Lyngby, Denmark Operational
Geras SolutionsDigital platform for cognitive impairment assessment and management Stockholms kommun, Sweden Operational
NeurocareNeurocare group develops personalized digital therapies to improve patients' mental health Munich, Germany Acquired
COMPASS PathwaysPsilocybin-based therapies for treatment-resistant mental health conditions London, United Kingdom Operational
Valera HealthOffering personalized mental health services combining meditation, therapy, and medications wrapped around with technology New York City, United States Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

23 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed15 investors entered at this stage

  • Y Combinator
  • GV
  • Martin Ventures
  • Lifeforce Capital
  • Byers Capital
  • Jeff Huber
  • Ben Silbermann
  • Gerald Bisbee
  • Rohan Seth
  • Ron Conway
  • Joe Kraus
  • Divya Gugnani
  • David Hodgson
  • Adam M
  • Rebel Fund

Series A7 investors entered at this stage

Other known investors1 additional known investor

  • Jonathan Hirsch
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇺🇸 United States97.3%
🇮🇹 Italy1.3%
🇬🇧 United Kingdom1.3%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SynaptiCure on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SynaptiCure’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.